Altria Group (MO)
$46.70
0.00 (0.00%)
MO Stock Quote Delayed 15 Minutes
Previous Close
$46.70
Market Cap
88.39B
PE Ratio
8.35
EPS
5.59
Volume (Avg. Vol.)
10
Day's Range
46.70 - 46.70
52-Week Range
42.40 - 66.04
Dividend & Yield
2.86 (6.12%)
MO Stock Predictions, Articles, and Altria Group News
Make This One Move When the Markets Get Bloody
Don't panic and sell everything when the Dow or S&P 500 take a dive. Do this instead to set up for the future.
There Are Better Pot Plays Than CRON Stock
With full commercial marijuana in the United States years away, there is plenty of time to place your bets on the cannabis sector. With the market overvalued, it may pay to wait things out until a screaming buy emerges. This is especially the case with Cronos. While the company may see parabolic growth in the next few years, much of this is reflected in the current share price. The partnership with Altria gives the company a solid strategic partner. But the highly dilutive nature of the deal minimizes potential upside.
3 Potential Catalysts That Could Send Tilray Shares Soaring
Despite falling from the highs, TLRY has potential. Here are three potential positive catalysts that could unlock Tilray's potential.
Cronos Stock Will Benefit From Altria, but Only in the Distant Future
The near-term future of CRON stock appears uncertain, but the relationship with Altria could make it succeed as a different type of equity.
Aphria Stock Needs Support It Won’t Get to Keep from Dropping More
Aphria stock hasn't been trading well, like most of its cannabis stock peers. Is the stock undervalued or unhealthy at current levels?
Did Cronos Group Just Become a Big-Time Sell?
Although CRON stock has held up better than some of its peers, sector volatility appears ready to take it down too.
Cronos Needs to Show the Market Something to Pull Stock Out of Funk
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
This Classic Buying Strategy Will Work Wonders With Disney Stock
Disney stock is a classic example of investors buying what they see and know, and that approach to DIS is looking even better now.
3 Big Stock Charts for Monday: Medtronic, Paychex and AbbVie
The stock charts of Medtronic, Paychex and AbbVie are poised to get the new trading week started with a bang.
After a Bumpy Few Months, Cronos Stock Is Back on the Move
Cronos may have $2 billion in cash but it is strategic in the way it spends that. So far the right moves are helping Cronos stock.
10 Smart Dividend Stocks for the Rest of the Year
Ford, Verizon and AbbVie are just a trio of the top dividend stocks to buy for the remainder of 2019, particularly if the broad market hits turbulence.
It’s Time to Load Up on CGC Stock Again
Canopy Growth is up more 65% year to date and that is four times the performance of the S&P 500. This trend is likely to continue.
Collect Income on Altria While it’s Down
This morning, I am recommending a bullish trade on Altria Group, Inc. (NYSE:MO).
The Bullish Thesis for Tilray Stock Is Still Alive and Well
Skeptics have lost fortunes trying to short Amazon and Netflix. They shouldn't make the same mistake with cannabis stocks like TLRY stock.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
